Floatz logo

Lorazepam

Psychoses

University of MichiganSmall moleculePhase 4 / ApprovedDormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Psychoses cohort.

Asset / SponsorPhaseRating
SERINE D-FORM
University of Minnesota
Phase 3BB
11c-sarcosine
Herzog Hospital
Phase 2B
Acp-103
ACADIA Pharmaceuticals Inc.
Phase 2B
Daaoi-1
China Medical University Hospital
Phase 2B

Same molecule, other indications

Lorazepam is also rated in:

schizoaffective disorderDormant
BBB
Indicative ·
73 / 100
View asset →
bipolar disorderDormant
BB
Indicative ·
69 / 100
View asset →
major depressive disorderDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →